Manufacturer:Peptide Sciences USA
Substance:PNC-27 Anti-Cancer Peptide
Package qty.:vial / (5 mg)
SKU: P5075
PNC-27 5 mg by Peptide Sciences USA
Brand: Peptide Sciences USA
Substance: PNC-27 Anti-Cancer Peptide
Action of the Drug
PNC-27 is a research peptide designed to selectively target and destroy cancer cells while leaving healthy cells intact. It works by binding to cell membranes and inducing apoptosis, making it a subject of interest in cancer research.
Use in Sports
PNC-27 is not intended for athletic performance or bodybuilding use. Its role is strictly within research fields, particularly oncology studies.
Period of Drug Withdrawal
As a research peptide, PNC-27 is rapidly metabolized and does not require a withdrawal period.
Rate of Suppression of Natural Testosterone Production
PNC-27 does not influence testosterone production or hormonal balance.
What Should Be Used During and After Use
During use:
- Close monitoring in research settings
- Combination with cell culture or experimental models
After use:
- No post-cycle therapy is required
- Results depend on experimental conditions
Combinations with Other Anabolic and Androgenic Drugs
PNC-27 is not combined with anabolic or androgenic compounds. Its applications remain strictly within oncology and peptide research.
Possible Side Effects and How to Avoid Them
- Limited research suggests low risk of side effects
- Use is restricted to controlled studies
Why We Recommend It
PNC-27 is recommended for advanced researchers interested in exploring targeted cancer cell apoptosis and peptide-based oncology applications.
Comparison with Other Drugs
Unlike conventional chemotherapy agents, PNC-27 shows promise in selectively targeting cancer cells, minimizing potential damage to healthy tissue in laboratory studies.
Main Properties
- Targeted Apoptosis: Induces cell death in cancer cells
- Selective Action: Spares healthy tissue
- Research Potential: Studied in oncology and apoptosis pathways
PNC-27 5 mg by Peptide Sciences USA is a specialized research peptide designed for exploring targeted cancer therapies in scientific studies.